Amendment: SEC Form SC 13G/A filed by Enovis Corporation

11/14/24 1:28:31 PM ET

Industrial Specialties

Health Care

Get the next $ENOV alert in real time by email

SC 13G/A 1 enov13gasep24.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) ENOVIS CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 194014502 (CUSIP NUMBER) September 30, 2024 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 6,617,377 6. Shared Voting Power* 0 7. Sole Dispositive Power* 6,632,634 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 6,632,634 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 11.9% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: ENOVIS CORP Item 1(b) Address of Issuer's Principal Executive Offices: 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON, DELAWARE 19808 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 194014502 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. (2) [T. ROWE PRICE MID-CAP GROWTH FUND ]: T. ROWE PRICE MID-CAP GROWTH FUND, of which T. Rowe Price Investment Management, Inc. is the investment adviser, holds the securities reported herein in their investment portfolio managed by T. Rowe Price Investment Management, Inc. and such funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that they hold. T. ROWE PRICE MID-CAP GROWTH FUND has an interest in 3,204,100 of the class reported herein representing 5.7% of the class. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: November 14, 2024 Signature: /s/ Ellen York Name & Title: Ellen York, Vice President 09/30/2024

Get the next $ENOV alert in real time by email

Recent Analyst Ratings for

$ENOV

Date	Price Target	Rating	Analyst
7/9/2026	$29.00	Outperform	BMO Capital Markets
4/17/2026		Outperform	William Blair
1/6/2026	$41.00	Buy	BTIG Research
10/3/2024	$62.00	Mkt Outperform	JMP Securities
6/13/2024	$53.00	Neutral	JP Morgan
2/13/2024	$72.00	Overweight	Stephens
1/22/2024	$75.00	Buy	UBS
1/3/2024		Outperform	William Blair

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Enovis Corporation

11/14/24 1:28:31 PM ET

$ENOV

Industrial Specialties

Health Care

Get the next $ENOV alert in real time by email

Recent Analyst Ratings for

$ENOV

Date	Price Target	Rating	Analyst
7/9/2026	$29.00	Outperform	BMO Capital Markets
4/17/2026		Outperform	William Blair
1/6/2026	$41.00	Buy	BTIG Research
10/3/2024	$62.00	Mkt Outperform	JMP Securities
6/13/2024	$53.00	Neutral	JP Morgan
2/13/2024	$72.00	Overweight	Stephens
1/22/2024	$75.00	Buy	UBS
1/3/2024		Outperform	William Blair

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Enovis Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ENOV

Amendment: SEC Form SC 13G/A filed by Enovis Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ENOV

$ENOV
SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by Enovis Corporation

SEC Form 11-K filed by Enovis Corporation

SEC Form SD filed by Enovis Corporation

$ENOV
Press Releases

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

$ENOV
Insider Purchases

Chief Administrative Officer Engert Oliver bought $20,920 worth of shares (1,000 units at $20.92), increasing direct ownership by 2% to 53,640 units (SEC Form 4)

Chief Administrative Officer Engert Oliver bought $25,948 worth of shares (1,200 units at $21.62), increasing direct ownership by 2% to 51,840 units (SEC Form 4)

Chief Administrative Officer Engert Oliver bought $23,000 worth of shares (1,000 units at $23.00), increasing direct ownership by 2% to 50,640 units (SEC Form 4)

$ENOV
Analyst Ratings

BMO Capital Markets initiated coverage on Enovis Corporation with a new price target

William Blair resumed coverage on Enovis Corporation

BTIG Research initiated coverage on Enovis Corporation with a new price target

$ENOV
Insider Trading

Director Ortiz Christine was granted 846 shares, increasing direct ownership by 3% to 25,857 units (SEC Form 4)

Chief Administrative Officer Engert Oliver bought $20,920 worth of shares (1,000 units at $20.92), increasing direct ownership by 2% to 53,640 units (SEC Form 4)

Amendment: Chief Administrative Officer Engert Oliver was granted 1,000 shares, increasing direct ownership by 2% to 52,640 units (SEC Form 4)

$ENOV
Financials

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Enovis Announces First Quarter 2026 Results

Enovis to Host First Quarter 2026 Results Conference Call on May 7th

$ENOV
Leadership Updates

Enovis Appoints Oliver Engert as Chief Administrative Officer

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

$ENOV
Large Ownership Changes